FIELD: medicine.
SUBSTANCE: before and after treating chronic heart disease, modified LP(a) are determined as follows. Blood serum 0.6 ml is treated with 0.1% Triton X-100 0. 2 ml, incubated for 15 minutes at 20°C. Then 7% polyethylene glycol 6000 is added, incubated with the Sudan Black stain at 40°C for 1 h; it is followed with electrophoretic separation of LP in agarose gel in a cavity 4×20 mm. The decreasing level of modified LP(a) by 40% and more in comparison with the primitive level, treating chronic heart disease treatment is considered as effective.
EFFECT: higher accuracy of estimating clinical effectiveness of chronic heart disease.
1 tbl, 6 dwg, 3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF ESTIMATING EFFICIENCY OF ISCHEMIC HEART DISEASE TREATMENT | 2010 |
|
RU2439581C1 |
| METHOD FOR ESTIMATING CLINICAL EFFECTIVENESS OF ISCHEMIC HEART DISEASE | 2011 |
|
RU2462722C1 |
| METHOD OF PREDICTING COURSE OF CORONARY HEART DISEASE | 2009 |
|
RU2398239C1 |
| METHOD FOR PREDICTION OF CLINICAL COURSE OF ISCHEMIC HEART DISEASE | 2012 |
|
RU2507518C1 |
| METHOD OF PREDICTING ISCHEMIC HEART DISEASE COURSE | 2010 |
|
RU2439582C1 |
| METHOD OF PREDICTING COURSE OF ISCHEMIC HEART DISEASE | 2011 |
|
RU2470294C1 |
| METHOD OF DETERMINING FRACTIONS OF MODIFIED LIPOPROTEINS IN BLOOD | 2009 |
|
RU2413952C2 |
| METHOD OF FRACTION TEST OF MODIFIED BLOOD LIPOPROTEINS | 2010 |
|
RU2428698C1 |
| METHOD OF FRACTIONAL ANALYSIS OF MODIFIED BLOOD LIPOPROTEINS | 2007 |
|
RU2364873C1 |
| METHOD FOR PREDICTION OF CLINICAL COURSE OF ISCHEMIC HEART DISEASE | 2012 |
|
RU2520755C1 |
